DARPA

Infectious diseases pose a significant global health challenge, accounting for a substantial proportion of deaths worldwide, according to recent data from the World Health Organization. Vanderbilt’s Life Science Showcase: Advancing Innovation in Infectious Diseases held on July 18 emphasized the vital importance of advancing research and innovation to combat these persistent threats. Read More

Daniel Balasubramanian, a senior research scientist at Vanderbilt’s Institute for Software Integrated Systems, will lead a four-year $6.89 million grant from the Defense Advanced Research Projects Agency to create realistic network environments used to train cyber agents to counter advanced and persistent cyber threats. Read More

Daniel Balasubramanian, a senior research scientist at Vanderbilt’s Institute for Software Integrated Systems, will lead a four-year $6.89 million grant from the Defense Advanced Research Projects Agency (DARPA) to create realistic network environments used to train cyber agents to counter advanced and persistent cyber threats. Estimates have placed the cost of global cybercrime as high... Read More

Daniel Balasubramanian, a senior research scientist at Vanderbilt’s Institute for Software Integrated Systems, will lead a four-year $6.89 million grant from the Defense Advanced Research Projects Agency (DARPA) to create realistic network environments used to train cyber agents to counter advanced and persistent cyber threats. Estimates have placed the cost of global cybercrime as high... Read More

Soheil Kolouri, assistant professor of computer science, is part of a team that has received a $1 million award from the Defense Advanced Research Projects Agency as part of the agency’s Shared-Experience Lifelong Learning initiative. Read More

By Aaron Conley Systems biology and the Lopez lab The history of hermeneutics started with Aristotle—parts comprise the whole. To understand the whole, we need to understand the parts. And to understand the parts, we need to understand them in the context of the whole. Carlos F. Lopez, associate… Read More

Vanderbilt researchers examine how to rapidly characterize the biological impact of genetic editing on bacteria for energy production, drug discovery and more. Est. reading time: 2.5 mins. Read More

A Vanderbilt engineering professor is leading part of an international initiative to create advanced artificial intelligence programs that will enable machines to learn progressively over a lifetime and share those experiences with each other. Researchers hope the technology will allow machines to reuse information, adapt quickly to new conditions and collaborate by sharing information. Read More

Kolouri wins $1M DARPA grant to investigate AI cooperative lifelong learning A Vanderbilt engineering professor is leading part of an international initiative to create advanced artificial intelligence programs that will enable machines to learn progressively over a lifetime and share those experiences with each other. Researchers hope the technology will allow machines to reuse information,... Read More

A monoclonal antibody cocktail against the COVID-19 virus discovered at VUMC is the first non-vaccine modified to demonstrate the prevention of COVID-19 in a clinical trial of more than 5,000 participants. The antibody treatment could afford up to 12 months of protection from COVID-19, and preliminary laboratory findings also suggest that it can neutralize the delta variant. Read More

United States Space Force Chief of Space Operations Gen. John W. "Jay" Raymond recently visited Vanderbilt to learn about the pioneering aerospace engineering projects at the university’s research institutes and trans-institutional programs. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read More

A new, $8.7 million project—Design. R–AI-assisted CPS Design—involves pathbreaking work for the Defense Advanced Research Projects Agency as future cyber-physical systems will rely less on human control and more machine learning algorithms and artificial intelligence processors. Read More

All software is not created equal. At one end are apps on a smartphone and consumer-facing programs for which periodic updates to fix bugs and security issues are routine, like replacing an air conditioning filter or getting an annual flu shot. At the other end are large, complex software systems such as software used in... Read More

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. Read More

Vanderbilt Vaccine Center team isolates monoclonal antibodies against the mosquito-borne Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months. Read More

Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies. Read More

Stimulating the vagus nerve triggers certain epigenetic changes involving learning and memory. Read More

Scientists at Vanderbilt's Institute for Software Integrated Systems have developed an award-winning AI to to help triage limited radio frequency demands in real time. Read More